Evidence map›Paper›PMID 36820416›Full record

ArticleJSES international2023

Glenoid microfracture in active-duty military patients: minimum 5-year follow-up demonstrates 75% survival.

John P Scanaliato, Alexis B Sandler, Michael D Baird, John C Dunn, Jason Uhlinger, Nata Parnes

Open access · goldAbstract read
In one paragraph

Article in JSES international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

John P ScanaliatoWilliam Beaumont Army Medical Center, Department of Orthopaedic Surgery, El Paso, TX, USA.
Alexis B SandlerWilliam Beaumont Army Medical Center, Department of Orthopaedic Surgery, El Paso, TX, USA.
Michael D BairdWalter Reed National Military Medical Center, Department of Orthopaedic Surgery, Bethesda, MD, USA.
John C DunnWilliam Beaumont Army Medical Center, Department of Orthopaedic Surgery, El Paso, TX, USA.
Jason UhlingerCarthage Area Hospital, Department of Orthopaedic Surgery, Carthage, NY, USA.
Nata ParnesCarthage Area Hospital, Department of Orthopaedic Surgery, Carthage, NY, USA.
William Beaumont Army Medical Center · USCarthage College · USWalter Reed National Military Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To present midterm patient-reported outcomes and survivorship data of active-duty military patients undergoing microfracture for full-thickness cartilage defects of the glenoid. Methods: All consecutive patients from January 2013 through December 2016 who underwent glenoid microfracture for full-thickness cartilage injuries with complete outcome scores were identified. Twenty patients met the final inclusion criteria for the study, and all were active-duty military at the time of surgery. A separate subgroup analysis was performed to determine if dominant-shoulder involvement portends worse outcomes. Results: The mean follow-up was 81.45 ± 19.43 months (range, 60-108). Of the 20 patients, 5 required a secondary surgical procedure within 5 years of their index procedure, with an average time to failure of 45.6 ± 13.15 months. For the 15 patients who did not fail, there was a statistically significant increase in the mean American Shoulder and Elbow Surgeons score (57.20 vs. 88.27, Conclusion: Glenoid microfracture can result in pain relief and symptomatic improvement for a select group of active-duty military patients, with 75% survivorship at 5 years. Approximately one in three (35%) patients, however, were unable to remain on active-duty military service.

Indexed as

Chondral defectChondral injuryChondral lesionGlenoidGlenoid microfractureMicrofractureMilitary

Identifiers

PMID36820416
PMCPMC9937841
OpenAlexW4306318691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.